News
19h
MedPage Today on MSNDurable Survival Outcomes in Advanced Melanoma With Neoadjuvant Dual ImmunotherapyParticipants received 480 mg of nivolumab and 160 mg of relatlimab intravenously once every 4 weeks for two cycles before ...
The 24-year study of more than 1.2 million children in Denmark found that aluminum exposure didn't raise the risk of autism, asthma, or other chronic diseases. Other science and research news is on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results